Donor-specific antibodies' C1q binding: improvement in kidney graft management? - Wikidata - wikimedia - TriplyDB

Donor-specific antibodies' C1q binding: improvement in kidney graft management?

Donor-specific antibodies' C1q binding: improvement in kidney graft management?

http://www.wikidata.org/entity/Q48271656

about

Donor-specific antibodies' C1q binding: improvement in kidney graft management?

http://www.wikidata.org/entity/Q48271656

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Donor-specific antibodies' C1q binding: improvement in kidney graft management?

@en

Donor-specific antibodies' C1q binding: improvement in kidney graft management?

@nl

type

label

Donor-specific antibodies' C1q binding: improvement in kidney graft management?

@en

Donor-specific antibodies' C1q binding: improvement in kidney graft management?

@nl

prefLabel

Donor-specific antibodies' C1q binding: improvement in kidney graft management?

@en

Donor-specific antibodies' C1q binding: improvement in kidney graft management?

@nl

P1433

Q48271656-730FEFB5-1E33-4520-9E0B-32C7B7A30776

P1476

Q48271656-C0BCD692-C3E0-414E-A5BE-28A6579BA57B

P2093

Q48271656-826C3928-CAFF-41FB-BAF5-01A6161F6574

P2860

Q48271656-01A50666-E41E-4727-9E94-698CBA620698

Q48271656-0596885A-0C39-4939-B473-9AFB999F6960

Q48271656-07BED8E1-CCE8-4FA8-99F8-0F716E5AAC52

Q48271656-0C5E9A33-AE64-46C5-97D4-0332D14E00BC

Q48271656-0D6D1845-B1AE-486B-85C9-EDE0F5301635

Q48271656-1D8509E0-FDF8-4C38-9303-04D8DAE288CA

Q48271656-6055B7F2-2F4D-4E1A-B32A-3D614D9005DB

Q48271656-76189BC9-83C3-4AA6-9F58-DF2C768B7D46

Q48271656-7A3EF1BE-3347-47D0-AC82-8CB32703CFEA

Q48271656-87B0E3A0-0641-43E4-9F89-0A4BAF1A1648

P304

Q48271656-FA0F888F-1F98-452B-9EA8-132D6F5CC6AA

P31

Q48271656-43B8C3BE-9513-48D0-807F-ABC1E948DB82

P356

Q48271656-E3875AAA-6A50-49D4-96DE-D71735C8F38F

P433

Q48271656-138304D0-65FE-4C22-A877-3A62EEA345A8

P478

Q48271656-838185A3-849F-4FA3-9E78-A79643ED8E28

P50

Q48271656-630E3471-582D-4DA2-B22E-A06639D9550B

P577

Q48271656-CDFD6378-E25E-42C6-9DD1-8242B2E5CD76

P698

Q48271656-BAC5F89C-BF39-4B9A-9BDB-D96DCBB963C9

P356

P1433

Transplant International

P1476

Donor-specific antibodies' C1q binding: improvement in kidney graft management?

@en

P2093

Sylvie Ferrari-Lacraz

http://www.w3.org/2001/XMLSchema#string

P2860

The collaborative transplant study registry.

Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival.

De novo donor-specific anti-HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q-binding ability.

Center-defined unacceptable HLA antigens facilitate transplants for sensitized patients in a multi-center kidney exchange program.

Quantifying the risk of incompatible kidney transplantation: a multicenter study.

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.

Complement-binding anti-HLA antibodies and kidney-allograft survival.

Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?

Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.

Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.

P304

344-346

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRI.12933

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Sylvie Ferrari-Lacraz

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28166393

http://www.w3.org/2001/XMLSchema#string